Home Yarrow

Yarrow

In operation
-
ASO Therapy Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Yarrow is developing ASO therapies for the treatment of severe, genetically determined central nervous system disorders. Yarrow was founded and incubated by RTW Investments in New York.
Yarrow Bioscience, Inc.
NewYork,NewYork,United States of America
unclear
May 26, 2021
--
--

Enterprise Profile

Industrial Sector
New Drug Development Scientific Research and Experimental Development Services
Concept
# Nervous System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Small Nucleic Acid Drugs